SCHEMBL16095565

SCHEMBL16095565

CCc1n[nH]c2cc(N)ccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AXL P30530 3/20 0.50
▸ PDPK1 O15530 6/20 0.42
▸ GSK3B P49841 2/20 0.41
▸ JAK2 O60674 2/20 0.41
▸ FGFR1 P11362 1/20 0.40
▸ FGFR2 P21802 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ PKM P14618 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ IMPDH2 P12268 1/20 0.36
▸ AURKA O14965 2/20 0.36
▸ TGFBR1 P36897 1/20 0.36
▸ AURKB Q96GD4 1/20 0.36
▸ PARP1 P09874 1/20 0.36
▸ PDE3B Q13370 1/20 0.36
▸ PDE3A Q14432 1/20 0.36
▸ GRM4 Q14833 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3352618 0.86 GSK3B (0.51) AXLPDPK1GSK3BJAK2KDM4E
SCHEMBL2914448 0.82 AXL (0.47) AXLPDPK1GSK3BJAK2FGFR1
SCHEMBL13726913 0.81 AXL (0.47) AXLPDPK1GSK3BJAK2FGFR1
SCHEMBL130781 0.80 ITK (0.47) MAPTPDE3BPDE3A
SCHEMBL10189221 0.80 KIF11 (0.47) GSK3BFGFR1MEN1KMT2APDE3B
SCHEMBL5790250 0.79 PDE3B (0.36) AXLPDPK1GSK3BJAK2FGFR1
SCHEMBL176792 0.79 PDPK1 (0.54) PDPK1GSK3BJAK2FGFR1FGFR2
SCHEMBL11388 0.79 PDPK1 (0.58) AXLPDPK1GSK3BJAK2AURKB
SCHEMBL5677771 0.79 MAP2K4 (0.51) GSK3B
SCHEMBL10271450 0.79 GSK3B (0.51) GSK3BCHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017153952-A1 5-SULFAMOYL-2-HYDROXYBENZAMIDE DERIVATIVES GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2017-09-14 — — WO disclosed
EP-2970211-A1 HISTONE DEMETHYLASE INHIBITORS Quanticel Pharmaceuticals Inc (US) 2016-01-20 — — EP disclosed
WO-2014151106-A1 HISTONE DEMETHYLASE INHIBITORS Quanticel Pharmaceuticals, Inc. (US) 2014-09-25 — — WO disclosed
Send feedback